Robert Torray Torray Investment Partners
Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$16.4M |
| 2 |
Danaher
DHR
|
+$15.6M |
| 3 |
RTX Corp
RTX
|
+$15.6M |
| 4 |
Qualcomm
QCOM
|
+$15.4M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$5.4M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$2.23M |
| 3 |
General Dynamics
GD
|
+$1.99M |
| 4 |
Wells Fargo
WFC
|
+$1.84M |
| 5 |
Johnson & Johnson
JNJ
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.29% |
| 2 | Healthcare | 15.9% |
| 3 | Industrials | 13.2% |
| 4 | Financials | 13.04% |
| 5 | Energy | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Church & Dwight Co
CHD
$23.4B
| $276K | 0.03% |
7,880
+1,530
| +24% | +$52.6K |
|
77
O'Reilly Automotive
ORLY
$72.1B
| $276K | 0.03% |
27,450
+2,775
| +11% | +$27.4K |
|
78
Quanta Services
PWR
$96.1B
| $262K | 0.03% |
7,590
+815
| +12% | +$28.2K |
|
|
FEIC
79
DELISTED
FEI COMPANY
FEIC
| $242K | 0.02% |
2,665
+275
| +12% | +$24.2K |
|
80
Jack Henry & Associates
JKHY
$11.8B
| $240K | 0.02% |
4,035
+410
| +11% | +$23.4K |
|
81
Copart
CPRT
$31.3B
| $238K | 0.02% |
52,960
+5,440
| +11% | +$24.5K |
|
82
Hexcel
HXL
$7.1B
| $237K | 0.02% |
5,785
+1,005
| +21% | +$41.8K |
|
83
Chevron
CVX
$403B
| $235K | 0.02% |
1,800
| – | – |
|
|
CTRX
84
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $234K | 0.02% |
+5,310
| New | +$225K |
|
85
Flowserve
FLS
$10.1B
| $229K | 0.02% |
3,080
+315
| +11% | +$23.9K |
|
86
Middleby
MIDD
$5.22B
| $229K | 0.02% |
2,765
+380
| +16% | +$31.3K |
|
87
Qualys
QLYS
$6.3B
| $222K | 0.02% |
+8,630
| New | +$196K |
|
88
World Kinect Corp
WKC
$1.84B
| $219K | 0.02% |
+4,440
| New | +$203K |
|
|
MDVN
89
DELISTED
MEDIVATION, INC.
MDVN
| $217K | 0.02% |
+5,620
| New | +$189K |
|
90
Consolidated Edison
ED
$39.3B
| – | – |
-7,750
| Closed | -$416K |
|
91
JPMorgan Chase
JPM
$935B
| – | – |
-8,700
| Closed | -$528K |
|
|
92
Vertex Pharmaceuticals
VRTX
$139B
| – | – |
-76,397
| Closed | -$5.4M |
|
Similar funds
Robert Torray's Q2 2014 Portfolio in Review
As of Q2 2014, Robert Torray held 94 positions worth $987M, up 67% from $590M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Robert Torray deployed $349M of net new capital in Q2 2014, opening 7 new positions and adding to 45 existing holdings. Its largest new stake was DIRECTV COM STK (DE): 120,200 shares worth $10.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Du Pont De Nemours E I, an estimated $2.23M trimmed.
- Robert Torray's largest Q2 2014 buy was DIRECTV COM STK (DE): 120,200 shares worth $10.2M.
- Robert Torray added most to Visa in Q2 2014, an estimated $16.4M increase.
- Robert Torray's biggest Q2 2014 reduction was Du Pont De Nemours E I, cutting an estimated $2.23M.
- Robert Torray fully exited Vertex Pharmaceuticals in Q2 2014, selling an estimated $5.4M.
- Robert Torray's ten largest holdings make up 26% of its $987M portfolio in Q2 2014.
- Robert Torray opened 7 new positions and closed 3 in Q2 2014.
- Robert Torray's portfolio value rose 67% quarter-over-quarter to $987M.
Based on Torray Investment Partners's 13F filing for Q2 2014, filed 14 Aug 2014.